Boundless Bio, Inc. (BOLD) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2025)

-$58.2M

Total Assets (FY2025)

$157.1M

Total Equity (FY2025)

$98.7M

Cash Flows from Operating Activities (FY2025)

-$46.7M

Source: Boundless Bio, Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.